Treatment and parameters | AST (U/L) | ALT (U/L) | ALP (U/L) | LDH (U/L) | γ-GT (U/L) |
---|---|---|---|---|---|
Control | 164.82 ± 1.28 | 65.88 ± 1.44 | 149.61 ± 2.19 | 20.81 ± 0.52 | 3.17 ± 0.39 |
CCl4 | 524.12 ± 5.11*** | 179.23 ± 3.39*** | 217.47 ± 8.55*** | 40.66 ± 0.81*** | 5.43 ± 0.21*** |
SL/CCl4 | 191.15 ± 2.14### | 87.82 ± 7.61### | 157.50 ± 5.12## | 28.62 ± 0.62### | 3.47 ± 0.06### |
MpEOa/CCl4 | 479.89 ± 36.41 | 162.02 ± 9.18 | 202.42 ± 7.62 | 37.75 ± 1.35 | 4.45 ± 0.25 |
MpEOb/CCl4 | 356.82 ± 35.77## | 147.35 ± 5.67## | 186.74 ± 3.98# | 34.16 ± 1.35## | 4.06 ± 0.17## |
MpEOc/CCl4 | 216.80 ± 7.26### | 97.82 ± 6.98### | 165.96 ± 5.12### | 31.64 ± 5.12### | 3.51 ± 0.20### |
MpEOc | 160.80 ± 2.47 | 63.08 ± 1.16 | 139.77 ± 7.27 | 19.89 ± 0.18 | 2.81 ± 0.24 |